Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | SOD1 | P00441 | 2/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2093439 | 0.79 | SOD1 (0.50) | SOD1CYP1A2CYP2A6 | |
| SCHEMBL2094814 | 0.77 | SMN1; SMN2 (0.46) | SOD1RXRARXRBCYP2A6 | |
| SCHEMBL9487275 | 0.72 | PTGS2 (0.42) | PTGS2RXRARXRBCYP1A2CYP2A6 | |
| SCHEMBL660859 | 0.72 | RXRA (0.39) | PTGS2RXRARXRBCYP1A2CYP2A6 | |
| SCHEMBL439074 | 0.71 | PTGS2 (0.48) | PTGS2RXRARXRBCYP1A2CYP2A6 | |
| SCHEMBL28806252 | 0.71 | PTGS2 (0.48) | PTGS2RXRARXRBCYP1A2CYP2A6 | |
| SCHEMBL11258820 | 0.70 | ALDH1A1 (0.53) | PTGS2 | |
| SCHEMBL9572629 | 0.69 | ALOX5 (0.45) | — | |
| SCHEMBL3196057 | 0.69 | RXRA (0.36) | PTGS2SOD1RXRARXRBCYP1A2 | |
| SCHEMBL1190705 | 0.69 | ALDH1A1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7659416-B2 | Monomolecular conductive complex, conductive self-assembled film and assembly of electrode composed of metal and semiconductor making use of the same | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2010-02-09 | — | — | US | disclosed |
| US-20090036698-A1 | Monomolecular Conductive Complex, Conductive Self-Assembled Film and Assembly of Electrode Composed of Metal and Semiconductor Making Use of the Same | TOKYO INSTITUTE OF TECHNOLOGY | 2009-02-05 | — | — | US | disclosed |
| EP-1862453-A1 | MONOMOLECULAR CONDUCTIVE COMPLEX, CONDUCTIVE SELF-ASSEMBLED FILM AND ASSEMBLY OF ELECTRODE COMPOSED OF METAL AND SEMICONDUCTOR MAKING USE OF THE SAME | Tokyo Institute of Technology (JP) | 2007-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036698-A1 | Monomolecular Conductive Complex, Conductive Self-Assembled Film and Assembly of Electrode Composed of Metal and Semiconductor Making Use of the Same | CNTN1, GAP43, AP3M1 | PTGS2 4260/4885SOD1 45/4885RXRA 4474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.